Characteristic mutations, called kataegis, are detected in the genomes of cancer cells, and the observed base substitution patterns are consistent with those mediated by APOBEC3A and/or APOBEC3B [6,8,12,13]. This evidence concerns the gene APOBEC3B and cancer.